Ruxin X. Ji
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Age- and Phenotype-Specific Patterns of Atopic and Autoimmune Comorbidities in Alopecia Areata: A Cross-Sectional Study.
Journal: Journal of cutaneous medicine and surgery
Published: September 07, 2026
Lattice defect capturing interfacial free water from reconstructed hydrogen-bond networks for H2O2 electrosynthesis.
Journal: Chemical communications (Cambridge, England)
Published: July 14, 2026
Clinical Yield of Laboratory Monitoring During Ritlecitinib Treatment for Alopecia Areata: A Prospective Real-World Cohort Study.
Journal: Journal of the American Academy of Dermatology
Published: June 12, 2026
Dynamics of Lipid Profile in Patients With Alopecia Areata Treated With Ritlecitinib: A Descriptive, Retrospective, Real-World Study.
Journal: Journal of cutaneous medicine and surgery
Published: March 27, 2026
Real-World Efficacy of Ritlecitinib in Adolescent Patients With Alopecia Areata: A 36 Week Monocentric Real-Life Observational Study.
Journal: Journal of cutaneous medicine and surgery
Published: March 12, 2026
Efficiency and safety of JAK inhibitors for alopecia totalis and alopecia universalis
Journal: Zhonghua yi xue za zhi
Published: December 16, 2025
Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study.
Journal: Journal of the American Academy of Dermatology
Published: November 11, 2025
Real-world experience of JAK inhibitors in eyebrow regrowth for alopecia areata: A retrospective single-center study.
Journal: Journal of the American Academy of Dermatology
Published: September 30, 2025
Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study.
Journal: Acta dermato-venereologica
Published: September 29, 2025
Adjunctive Intramuscular Corticosteroids for Suboptimal Responders to Ritlecitinib in Alopecia Areata: A Case Series.
Journal: Journal of cutaneous medicine and surgery
Published: August 19, 2025
Sequential Immunotherapy with Tofacitinib and Low-Dose IL-2 Induces Sustained Remission in Alopecia Areata: A Proof-of-concept monocentric study.
Journal: QJM : monthly journal of the Association of Physicians
Published: June 30, 2025
Sequential immunotherapy with tofacitinib and low-dose IL-2 induces sustained remission in alopecia areata: a proof-of-concept monocentric study.
Journal: QJM : monthly journal of the Association of Physicians
Published: June 30, 2025
Last Updated: 09/26/2026